Drugs / Low dose aspirin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03674606 | Feb 2014 → Apr 2016 | fetal growth restriction, preeclampsia | University College Dublin | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low dose aspirin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03674606 ↗ |
| Route | Oral | “taking oral low-dose aspirin from the eligibility visit until 36-week gestation once daily” NCT03674606 ↗ |